<DOC>
	<DOCNO>NCT01685372</DOCNO>
	<brief_summary>The purpose study determine whether Fluzone High Dose increase immune response influenza antigen contain vaccine compare standard-dose Fluzone immunocompromised child young adult . Safety efficacy data also collect .</brief_summary>
	<brief_title>Immunogenicity Fluzone High Dose Immunocompromised Children Young Adults</brief_title>
	<detailed_description />
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Collagen Diseases</mesh_term>
	<mesh_term>Rheumatic Diseases</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Age ≥ 5 year ≤ 35 year Receiving influenza vaccination Children 's Hospital Colorado ( CHC ) clinic part routine clinical care Only suppose receive one dose influenza vaccine Rheumatology patient : must type immunosuppressive immunomodulatory medication time immunization consider least moderately immunosuppressed opinion primary rheumatologist . Basic guideline rheumatology patient : ( 1 ) Any patient receiving monoclonal antibody therapy ( i.e. , infliximab , etanercept , tocilizumab , anakinra ) must also take another immunosuppressive/immunomodulatory medication ; ( 2 ) Patients take steroid monotherapy must dose ≥ 2mg/kg/day OR ≥ 20mg/day ; ( 3 ) Patients combination therapy dose single drug may high , combination consider moderately severely immunosuppressive eligible . Bone Marrow Transplant patient : patient clinic eligible Oncology patient : must type chemotherapy Hemodialysis patient : must dialysis Child Health Immunodeficiency Program ( CHIP ) patient : must know diagnosis HIV Solid Organ Transplant patient : posttransplant , influenza vaccine recommend primary transplant physician Rheumatology patient : receive monoclonal antibody , etanercept , infliximab , adalimumab , tocilizumab , atlizumab , anakinra , must also take least one immunosuppressive/immunomodulatory medication Unable come schedule followup appointment History anaphylaxis reaction influenza vaccination past Severe allergic reaction component vaccine , include egg protein , previous dose influenza vaccine History GuillainBarre syndrome ever past subject parent sibling subject Allergy latex Intravenous immuneglobulin ( IVIG ) within 4 week precede blood draw Receiving investigational agent part another study medical treatment ( investigational = notFDA approve indication ) Subject enrol study prohibit him/her enrol study Blood draw contraindicate Pregnancy Breastfeeding Received polysaccharide vaccine ( pneumovax ) w/in 3 week vaccination Absolute neutrophil count ( ANC ) &lt; 500/uL time vaccination could potentially ANC 500/uL 5 day vaccination Platelet count &lt; 50,000/uL time vaccination If subject temperature ≥ 100.4°F time enrollment , subject must choose enroll delay immunization afebrile . Receiving influenza vaccination past December 15 influenza season .</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>